Stock Price Quote

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC
BSE9007.00-24.95 (-0.28 %)
PREV CLOSE ( ) 9031.95
OPEN PRICE ( ) 8979.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 677
TODAY'S LOW / HIGH ( )8971.35 9066.85
52 WK LOW / HIGH ( )5329.7 9370.35
NSE9000.45-41.25 (-0.46 %)
PREV CLOSE( ) 9041.70
OPEN PRICE ( ) 9000.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 9000.45 (3)
VOLUME 9451
TODAY'S LOW / HIGH( ) 8960.00 9100.00
52 WK LOW / HIGH ( )5400 9380
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-05 1956
Management Info
Aditya Narayan - Chairman Rodolfo Hrosz - Managing Director
Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

26Feb Sanofi India informs about outcome of
Sanofi India has informed that it enclosed the presentation made to the..
23Feb Scheme of Arrangement
Inter alia, approved :- 1. Approved convening of the 68th AGM of the..
22Feb Clarification Regarding Appointment O
We wish to clarify that each of the said appointments of Independent Dir..
21Feb Appointment Of Independent Directors
Please find enclosed intimation from Sanofi Consumer Healthcare India Li..
20Feb Sanofi India informs about newspaper p
Sanofi India has informed that it enclosed copies of the Notice to Share..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit13776032
Gross Profit 1888 8458
Operating Profit 19948693
Net Sales 693928511

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  28639.35 (0.55%)
M.Cap ( in Cr)60856.62
Bharat Parenterals (BSE)
peergroup  1147.65 (10.28%)
M.Cap ( in Cr)667.89
Astrazeneca Pharma I (BSE)
peergroup  5567.65 (1.95%)
M.Cap ( in Cr)13919.13
Neuland Laboratories (BSE)
peergroup  7063.75 (1.37%)
M.Cap ( in Cr)9062.71
Mankind Pharma (BSE)
peergroup  2097.55 (1.58%)
M.Cap ( in Cr)84025.43

Shareholding Pattern

FI/BANKS/INSURANCE 9.28%
PROMOTERS 60.4%
NON-INSTITUTION 12.46%
MUTUAL FUNDS/UTI 11.51%
GOVERNMENT 0%
FII 0%

About Sanofi India Ltd.

Sanofi India Ltd. was incorporated in the year 1956. Its today's share price is 9007. Its current market capitalisation stands at Rs 20743.68 Cr. In the latest quarter, company has reported Gross Sales of Rs. 27701 Cr and Total Income of Rs.28431 Cr. The company's management includes Radhika Shah, Vaibhav Karandikar, Marc-Antoine Lucchini, Usha Thorat, Rodolfo Hrosz, Aditya Narayan.

It is listed on the BSE with a BSE Code of 500674 , NSE with an NSE Symbol of SANOFI and ISIN of INE058A01010. It's Registered office is at Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, PowaiMumbai-400072, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are PC Hansotia & Co, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP, SR Batliboi & Co, SR Batliboi & Co LLP, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.